Prokidney Corp. SEC filings PROK
Prokidney Corp. has 401 filings in SEC EDGAR's recent list, going back to Apr 21, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 29, 2026 | — |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| POS AM | Filing | Oct 21, 2025 | — |
| 424B5 | Prospectus supplement | Jul 14, 2025 | — |
| POS AM | Filing | Jul 7, 2025 | — |
| S-8 POS | Filing | Jul 3, 2025 | — |
| S-8 POS | Filing | Jul 3, 2025 | — |
| S-8 POS | Filing | Jul 3, 2025 | — |
| S-8 POS | Filing | Jul 3, 2025 | — |
| POS AM | Filing | Jul 3, 2025 | — |
| 424B3 | Prospectus | Apr 28, 2025 | — |
| S-4 | Registration for a merger or exchange | Mar 31, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Jun 13, 2024 | — |
| 424B5 | Prospectus supplement | Jun 10, 2024 | — |
| S-8 | Employee stock plan registration | Mar 22, 2024 | — |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| S-3 | Shelf registration | Nov 22, 2023 | — |
| 424B3 | Prospectus | Aug 23, 2023 | — |
| POS AM | Filing | Aug 18, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| 424B3 | Prospectus | Jul 25, 2023 | — |
| 424B3 | Prospectus | Jul 6, 2023 | — |
| 424B3 | Prospectus | Jun 23, 2023 | — |
| 424B3 | Prospectus | May 26, 2023 | — |
| 424B3 | Prospectus | Apr 21, 2023 | — |
| POS AM | Filing | Apr 17, 2023 | — |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| 424B3 | Prospectus | Mar 7, 2023 | — |
| 424B3 | Prospectus | Feb 6, 2023 | — |
| 424B3 | Prospectus | Jan 20, 2023 | — |
| 424B3 | Prospectus | Jan 11, 2023 | — |
| 424B3 | Prospectus | Dec 8, 2022 | — |
| 424B3 | Prospectus | Nov 29, 2022 | — |
| S-8 | Employee stock plan registration | Sep 14, 2022 | — |
| 424B3 | Prospectus | Sep 9, 2022 | — |
| S-1/A | Amended registration statement | Aug 26, 2022 | — |
| S-1 | Registration statement | Aug 9, 2022 | — |
| 424B4 | Prospectus | Jul 1, 2021 | — |
| S-1MEF | Filing | Jun 30, 2021 | — |
| S-1/A | Amended registration statement | Jun 25, 2021 | — |
| S-1/A | Amended registration statement | Jun 9, 2021 | — |
| S-1 | Registration statement | Jun 2, 2021 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PROK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Winston-Salem, NC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850270
- Former names
- Social Capital Suvretta Holdings Corp. III (until Jul 11, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.